Clinical approaches to diagnosing and managing congenital toxoplasmosis
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20252148Keywords:
Congenital toxoplasmosis, Toxoplasma gondii, Clinical approaches, Diagnosis, ManagementAbstract
Toxoplasma gondii is a globally prevalent intracellular parasite, which is the causative agent of congenital toxoplasmosis, a disease that may lead to neonatal and fetal complications. Infection by Toxoplasma occurs through ingesting raw or undercooked meat containing still viable cysts. Accurate diagnosis and timely intervention during pregnancy are crucial for mitigating adverse effects. This review aims to summarize current clinical approaches for the diagnosis and management of congenital toxoplasmosis. Different diagnostic methods such as polymerase chain reaction (PCR), immunosorbent agglutination assay (ISAGA), Western blot, and enzyme-linked immunosorbent assay (ELISA) show varying degrees of specificity and sensitivity. Additionally, combined methods improve diagnostic accuracy. Prenatal treatment spiramycin or pyrimethamine-sulfonamide regimens show effectiveness in reducing vertical transmission and disease severity, particularly when started early. Management of congenital toxoplasmosis postnatally needs regular monitoring and prolonged therapy due to high risk of side effects. Recently, multiple tools have emerged like recombinant antigens, microRNAs, and vaccine candidates and seemed promise but require further validation. Congenital toxoplasmosis remains a diagnostic and therapeutic challenge. While current strategies improve outcomes, global implementation of standardized screening and the development of safer, more effective interventions are needed to further reduce disease burden.
Metrics
References
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501-8. DOI: https://doi.org/10.2471/BLT.12.111732
Nayeri T, Sarvi S, Moosazadeh M, Amouei A, Hosseininejad Z, Daryani A. The global seroprevalence of anti-Toxoplasma gondii antibodies in women who had spontaneous abortion: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14(3):e0008103. DOI: https://doi.org/10.1371/journal.pntd.0008103
Pittman KJ, Knoll LJ. Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections. Microbiol Mol Biol Rev. 2015;79(4):387-401. DOI: https://doi.org/10.1128/MMBR.00027-15
Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital Toxoplasmosis: The State of the Art. Front Pediatr. 2022;10:894573. DOI: https://doi.org/10.3389/fped.2022.894573
Losa A, Carvalho I, Sousa B, Ashworth J, Guedes A, Carreira L, et al. Diagnosis of Congenital Toxoplasmosis: Challenges and Management Outcomes. Cureus. 2024;16(1):e52971. DOI: https://doi.org/10.7759/cureus.52971
Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. 2021;148(12):1406-16. DOI: https://doi.org/10.1017/S0031182021001013
McAuley JB. Congenital Toxoplasmosis. J Pediatr Infect Dis Soc. 2014;3(1):S30-35. DOI: https://doi.org/10.1093/jpids/piu077
Kieffer F, Wallon M. Congenital toxoplasmosis. Handbook Clin Neurol. 2013;112:1099-101. DOI: https://doi.org/10.1016/B978-0-444-52910-7.00028-3
Teimouri A, Mahmoudi S, Behkar A, Sahebi K, Foroozand H, Hassanpour G, et al. Current and Emerging Techniques for Diagnosis of Toxoplasmosis in Pregnancy: A Narrative Review. Iran J Parasitol. 2024;19(4):384-96. DOI: https://doi.org/10.18502/ijpa.v19i4.17159
Márquez-Mauricio A, Caballero-Ortega H, Gómez-Chávez F. Congenital Toxoplasmosis Diagnosis: Current Approaches and New Insights. Acta Parasitologica. 2023;68(3):473-80. DOI: https://doi.org/10.1007/s11686-023-00693-y
Marra CM. Central nervous system infection with Toxoplasma gondii. Handbook Clin Neurol. 2018;152:117-22. DOI: https://doi.org/10.1016/B978-0-444-63849-6.00009-8
Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330(26):1858-63. DOI: https://doi.org/10.1056/NEJM199406303302604
Murat JB, Hidalgo HF, Brenier-Pinchart MP, Pelloux H. Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations? Exp Rev Anti-infect Ther. 2013;11(9):943-56. DOI: https://doi.org/10.1586/14787210.2013.825441
Christie E, Pappas PW, Dubey JP. Ultrastructure of excystment of Toxoplasma gondii oocysts. J Protozool. 1978;25(4):438-43. DOI: https://doi.org/10.1111/j.1550-7408.1978.tb04166.x
Costa JM, Ernault P, Gautier E, Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat Diagnosis. 2001;21(2):85-8. DOI: https://doi.org/10.1002/1097-0223(200102)21:2<85::AID-PD18>3.0.CO;2-1
Delhaes L, Filisetti D, Brenier-Pinchart MP. Freezing and storage at -20 °C provides adequate preservation of Toxoplasma gondii DNA for retrospective molecular analysis. Diagnost Microbiol Infect Dis. 2014;80(3):197-9. DOI: https://doi.org/10.1016/j.diagmicrobio.2014.08.007
Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect. 2015;21(2):191. DOI: https://doi.org/10.1016/j.cmi.2014.09.018
Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 2001;97(2):296-300. DOI: https://doi.org/10.1097/00006250-200102000-00024
Rostami A, Karanis P, Fallahi S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection. 2018;46(3):303-15. DOI: https://doi.org/10.1007/s15010-017-1111-3
Noruzi R, Dalimi A, Forouzandeh M, Ghaffarifar F. Identification of Live Toxoplasma gondii by the NASBA method in Rat. Pathobiol Res. 2012;15(1):73-80.
Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H. Relevance of and New Developments in Serology for Toxoplasmosis. Trends Parasitol. 2016;32(6):492-506. DOI: https://doi.org/10.1016/j.pt.2016.04.001
Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004;132(3):541-8. DOI: https://doi.org/10.1017/S0950268803001948
Olariu TR, Blackburn BG, Press C, Talucod J, Remington JS, Montoya JG. Role of Toxoplasma IgA as Part of a Reference Panel for the Diagnosis of Acute Toxoplasmosis during Pregnancy. J Clin Microbiol. 2019;57(2). DOI: https://doi.org/10.1128/JCM.01357-18
Matowicka-Karna J, Kemona H. IgE antibodies in toxoplasmosis. Postepy Hig Med Dosw (Online). 2014;68:597-602. DOI: https://doi.org/10.5604/17322693.1102581
Pinon JM, Toubas D, Marx C, Mougeot G, Bonnin A, Bonhomme A, et al. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol. 1990;28(8):1739-43. DOI: https://doi.org/10.1128/jcm.28.8.1739-1743.1990
Gross U, Keksel O, Dardé ML. Value of detecting immunoglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection. Clin Diagnost Lab Immunol. 1997;4(3):247-51. DOI: https://doi.org/10.1128/cdli.4.3.247-251.1997
Wong SY, Hajdu MP, Ramirez R, Thulliez P, McLeod R, Remington JS. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol. 1993;31(11):2952-9. DOI: https://doi.org/10.1128/jcm.31.11.2952-2959.1993
Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H. Role of Toxoplasma gondii IgG Avidity Testing in Discriminating between Acute and Chronic Toxoplasmosis in Pregnancy. J Clin Microbiol. 2020;58(9). DOI: https://doi.org/10.1128/JCM.00505-20
Flori P, Tardy L, Patural H, Bellete B, Varlet MN, Hafid J, et al. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol. 2004;11(4):669-74. DOI: https://doi.org/10.1128/CDLI.11.4.669-674.2004
Murat JB, L'Ollivier C, Fricker Hidalgo H, Franck J, Pelloux H, Piarroux R. Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results. Clin Vaccine Immunol. 2012;19(11):1838-43. DOI: https://doi.org/10.1128/CVI.00333-12
Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen. 2007;14(1):8-13. DOI: https://doi.org/10.1258/096914107780154440
Pomares C, Montoya JG. Laboratory Diagnosis of Congenital Toxoplasmosis. J Clin Microbiol. 2016;54(10):2448-54. DOI: https://doi.org/10.1128/JCM.00487-16
Maldonado YA, Read JS. Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics. 2017;139(2). DOI: https://doi.org/10.1542/peds.2016-3860
Capobiango JD, Monica TC, Ferreira FP, Mitsuka-Breganó R, Navarro IT, Garcia JL, et al. Evaluation of the Western blotting method for the diagnosis of congenital toxoplasmosis. J Pediatr (Rio J). 2016;92(6):616-23. DOI: https://doi.org/10.1016/j.jped.2016.02.014
Paquet C, Yudin MH. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Canad. 2013;35(1):78-81. DOI: https://doi.org/10.1016/S1701-2163(15)31053-7
Teixeira LE, Kanunfre KA, Shimokawa PT, Targa LS, Rodrigues JC, Domingues W, et al. The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev Soc Bras Med Trop. 2013;46(5):584-8. DOI: https://doi.org/10.1590/0037-8682-0095-2013
de Oliveira Azevedo CT, do Brasil PE, Guida L, Lopes Moreira ME. Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis. PloS One. 2016;11(4):e0149938. DOI: https://doi.org/10.1371/journal.pone.0149938
Rabilloud M, Wallon M, Peyron F. In utero and at birth diagnosis of congenital toxoplasmosis: use of likelihood ratios for clinical management. Pediatr Infect Dis J. 2010;29(5):421-5. DOI: https://doi.org/10.1097/INF.0b013e3181c80493
Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev. 2000;1999(2):Cd001684. DOI: https://doi.org/10.1002/14651858.CD001684
Prusa AR, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. The Austrian Toxoplasmosis Register, 1992-2008. Clin Infect Dis. 2015;60(2):e4-e10. DOI: https://doi.org/10.1093/cid/ciu724
Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet (London, England). 2007;369(9556):115-22. DOI: https://doi.org/10.1016/S0140-6736(07)60072-5
Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Rev. 2018;31(4). DOI: https://doi.org/10.1128/CMR.00057-17
Buonsenso D, Pata D, Turriziani Colonna A, Iademarco M, De Santis M, Masini L, et al. Spyramicine and Trimethoprim-Sulfamethoxazole Combination to Prevent Mother-To-Fetus Transmission of Toxoplasma gondii Infection in Pregnant Women: A 28-Years Single-center Experience. Pediatr Infect Dis J. 2022;41(5):e223-7. DOI: https://doi.org/10.1097/INF.0000000000003469
Peyron F, L'ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens. 2019;8(1):24. DOI: https://doi.org/10.3390/pathogens8010024
Fallahi S, Rostami A, Nourollahpour Shiadeh M, Behniafar H, Paktinat S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J Gynecol Obstet Hum Reprod. 2018;47(3):133-40. DOI: https://doi.org/10.1016/j.jogoh.2017.12.003
Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, et al; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010;7(10):e1000351. DOI: https://doi.org/10.1371/journal.pmed.1000351
McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Memorias do Instituto Oswaldo Cruz. 2009;104(2):320-44. DOI: https://doi.org/10.1590/S0074-02762009000200029
Alday PH, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Design Dev Ther. 2017;11:273-93. DOI: https://doi.org/10.2147/DDDT.S60973
Ben-Harari RR, Goodwin E, Casoy J. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Drugs R&D. 2017;17(4):523-44. DOI: https://doi.org/10.1007/s40268-017-0206-8
Santana SS, Paiva VF, Carvalho FR, Barros HLS, Silva TL, Barros PSC, et al. A peptide originated from Toxoplasma gondii microneme 8 displaying serological evidence to differentiate recent from chronic human infection. Parasitol Int. 2021;84:102394. DOI: https://doi.org/10.1016/j.parint.2021.102394
Frickel EM, Sahoo N, Hopp J, Gubbels MJ, Craver MP, Knoll LJ, et al. Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J Infect Dis. 2008;198(11):1625-33. DOI: https://doi.org/10.1086/593019
Hiszczyńska-Sawicka E, Kur J, Pietkiewicz H, Holec-Gasior L, G¹sior A, Myjak P. Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis. Acta Parasitologica. 2005;50:249-54.
Jia B, Chang Z, Wei X, Lu H, Yin J, Jiang N, et al. Plasma microRNAs are promising novel biomarkers for the early detection of Toxoplasma gondii infection. Parasit Vectors. 2014;7:433. DOI: https://doi.org/10.1186/1756-3305-7-433
Hu RS, He JJ, Elsheikha HM, Zhang FK, Zou Y, Zhao GH, et al. Differential Brain MicroRNA Expression Profiles After Acute and Chronic Infection of Mice With Toxoplasma gondii Oocysts. Front Microbiol. 2018;9:2316. DOI: https://doi.org/10.3389/fmicb.2018.02316
Tüfekci KU, Oner MG, Meuwissen RL, Genç S. The role of microRNAs in human diseases. Methods Mol Biol. 2014;1107:33-50. DOI: https://doi.org/10.1007/978-1-62703-748-8_3
Wang W, Sung N, Gilman-Sachs A, Kwak-Kim J. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front Immunol. 2020;11:2025. DOI: https://doi.org/10.3389/fimmu.2020.02025
Borges M, Magalhães Silva T, Brito C, Teixeira N, Roberts CW. How does toxoplasmosis affect the maternal-foetal immune interface and pregnancy? Parasite Immunol. 2019;41(3):e12606. DOI: https://doi.org/10.1111/pim.12606
Barros M, Teixeira D, Vilanova M, Correia A, Teixeira N, Borges M. Vaccines in Congenital Toxoplasmosis: Advances and Perspectives. Front Immunol. 2020;11:621997. DOI: https://doi.org/10.3389/fimmu.2020.621997
Ducournau C, Nguyen TT, Carpentier R, Lantier I, Germon S, Précausta F, Pet al. Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice. Future Microbiol. 2017;12:393-405. DOI: https://doi.org/10.2217/fmb-2016-0146
Beauvillain C, Juste MO, Dion S, Pierre J, Dimier-Poisson I. Exosomes are an effective vaccine against congenital toxoplasmosis in mice. Vaccine. 2009;27(11):1750-7. DOI: https://doi.org/10.1016/j.vaccine.2009.01.022
Wang JL, Elsheikha HM, Zhu WN, Chen K, Li TT, Yue DM, et al. Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice. Front Immunol. 2017;8:730. DOI: https://doi.org/10.3389/fimmu.2017.00730
Downloads
Published
How to Cite
Issue
Section
